Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2015, Article ID 318175, 5 pages
http://dx.doi.org/10.1155/2015/318175
Case Report

A Rare Case of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia

1Department of Surgery, Columbia University College of Physicians and Surgeons at Harlem Hospital, New York, NY 10037, USA
2Department of Surgery, New York University School of Medicine, New York, NY 10016, USA
3Department of Cardiothoracic Surgery, Harlem Hospital Center, New York, NY 10037, USA

Received 4 September 2015; Accepted 8 October 2015

Academic Editor: Francesco Petrella

Copyright © 2015 Godwin Ofikwu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. M. Aguayo, Y. E. Miller, J. A. Waldron Jr. et al., “Brief report: Idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease,” The New England Journal of Medicine, vol. 327, no. 18, pp. 1285–1288, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Swigris, S. Ghamande, T. W. Rice, and C. Farver, “Diffuse idiopathic neuroendocrine cell hyperplasia: An interstitial lung disease with airway obstruction,” Journal of Bronchology, vol. 12, no. 1, pp. 62–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Davies, J. R. Gosney, D. M. Hansell et al., “Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease,” Thorax, vol. 62, no. 3, pp. 248–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. W. D. Travis, E. Brambilla, H. K. Müller-Hermelink, and C. C. Harris, World Health Organization Classification of Tumours: Pathology & Genetics: Tumours of the Lung, Pleura, Thymus and Heart, IARC Press, Lyon, France, 2004.
  5. Z. Chen, L. W. Forman, K. A. Miller et al., “Protein kinase C-delta inactivation inhibits cellular proliferation and decreases survival in human neuroendocrine tumor,” Endocrine-Related Cancer, vol. 18, no. 6, pp. 759–771, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Leung, B. Lang, H. Wong et al., “Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy,” Anti-Cancer Agents in Medicinal Chemistry, vol. 13, no. 3, pp. 382–388, 2013. View at Publisher · View at Google Scholar · View at Scopus